These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3274269)
1. Cardiac allograft survival in ABO blood group incompatible baboons. Cooper DK; Lexer G; Rose AG; Rees J; Keraan M; Du Toit E; Oriol R Transplant Proc; 1987 Feb; 19(1 Pt 2):1036-8. PubMed ID: 3274269 [No Abstract] [Full Text] [Related]
2. Newborn discordant cardiac xenotransplantation in primates: a model of natural antibody depletion. Michler RE; Xu H; O'Hair DP; Shah A; Kwiatkowski PA; Minanov O; Itescu S Transplant Proc; 1996 Apr; 28(2):651-2. PubMed ID: 8623325 [No Abstract] [Full Text] [Related]
3. A novel approach to "neutralization" of preformed antibodies: cardiac allotransplantation across the ABO blood group barrier as a paradigm of discordant transplantation. Cooper DK; Ye Y; Kehoe M; Niekrasz M; Rolf LL; Martin M; Baker J; Kosanke S; Zuhdi N; Worsley G Transplant Proc; 1992 Apr; 24(2):566-71. PubMed ID: 1566432 [No Abstract] [Full Text] [Related]
5. In vivo evidence for the Th1/Th2 paradigm: oral alloantigen-induced modulation of accelerated allograft rejection is associated with dense intragraft IL-4. Hancock WW; Sayegh MH; Carpenter CB Transplant Proc; 1992 Oct; 24(5):2313-4. PubMed ID: 1413074 [No Abstract] [Full Text] [Related]
6. Cardiac allotransplantation across major blood group barriers in the baboon. Cooper DK; Lexer G; Rose AG; Keraan M; Rees J; Du Toit E; Oriol R J Med Primatol; 1988; 17(6):333-46. PubMed ID: 3065510 [TBL] [Abstract][Full Text] [Related]
7. Prolongation of rat cardiac allograft survival by hyperimmune blood transfusion without immunosuppression. Lee PC; Lei HY; Jin YT; Lee PH; Lee CJ Transplant Proc; 1994 Aug; 26(4):2323-6. PubMed ID: 8066761 [No Abstract] [Full Text] [Related]
8. Perfusion of rabbit hearts with human blood results in immediate graft thrombosis, which is temporally distinct from hyperacute rejection. Forty J; Hasan R; Cary N; White DJ; Wallwork J Transplant Proc; 1992 Apr; 24(2):610-1. PubMed ID: 1566450 [No Abstract] [Full Text] [Related]
9. Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting. Cooper DK; Good AH; Ye Y; Koren E; Oriol R; Ippolito RM; Malcolm AJ; Neethling FA; Romano E; Zuhdi N Transplant Proc; 1993 Feb; 25(1 Pt 1):377-8. PubMed ID: 8438342 [No Abstract] [Full Text] [Related]
10. Comparative immunopathologic study of hyperacute rejection in naive and sensitized rodent cardiac xenograft models. Wu GD; Cramer DV; Chapman FA; Wang HK; Chien K; Cole J; Makowka L Transplant Proc; 1993 Feb; 25(1 Pt 1):464-5. PubMed ID: 8438380 [No Abstract] [Full Text] [Related]
12. Accelerated cardiac allograft rejection associated with administration of liver cell extract in the baboon. Cooper DK; Harris N; Rose AG; Novitzky D Transplant Proc; 1990 Aug; 22(4):1966-9. PubMed ID: 2389499 [No Abstract] [Full Text] [Related]
13. Interference with intracellular carbohydrate processing by castanospermine prolongs heart allograft survival. Grochowicz PM; Bowen KM; Hibberd AD; Clark DA; Cowden WB; Willenborg DO; Husband A Transplant Proc; 1993 Feb; 25(1 Pt 1):743-4. PubMed ID: 8438464 [No Abstract] [Full Text] [Related]
14. Specific intravenous carbohydrate therapy. A new concept in inhibiting antibody-mediated rejection--experience with ABO-incompatible cardiac allografting in the baboon. Cooper DK; Ye Y; Niekrasz M; Kehoe M; Martin M; Neethling FA; Kosanke S; DeBault LE; Worsley G; Zuhdi N Transplantation; 1993 Oct; 56(4):769-77. PubMed ID: 8212194 [TBL] [Abstract][Full Text] [Related]